statistiche ricercatore

Città	#
Moscow	132
Munich	108
Dallas	85
Helsinki	61
Singapore	56
Verona	52
Ashburn	51
Hong Kong	50
Chandler	30
Dublin	21
Beijing	14
Los Angeles	13
New York	13
Guwahati	11
London	10
Milan	10
Turku	10
Gimpo-si	9
Cagliari	8
Jakarta	8
Brooklyn	7
Cotonou	7
Ho Chi Minh City	7
Lomé	7
The Dalles	7
Amsterdam	6
Council Bluffs	6
Denver	6
Johannesburg	6
Jyväskylä	6
Lappeenranta	6
Stockholm	6
Tokyo	6
Vienna	6
Ankara	5
Buffalo	5
Isola della Scala	5
Melbourne	5
Redondo Beach	5
Southend	5
Taipei	5
Warsaw	5
Cairo	4
Chicago	4
Gyeongsan-si	4
Kuala Lumpur	4
Nuremberg	4
Portland	4
Santa Clara	4
São Paulo	4
Tombolo	4
Baghdad	3
Boston	3
Brussels	3
Cape Town	3
Cincinnati	3
Columbus	3
Falkenstein	3
Houston	3
Kent	3
Kolkata	3
Lawrence	3
Modena	3
Nairobi	3
Nakamachi	3
Orem	3
Poplar	3
Princeton	3
Sahāranpur	3
Sant'Ambrogio di Valpolicella	3
Seattle	3
Sindelfingen	3
Todi	3
Washington	3
Wilmington	3
Ahmedabad	2
Al Maḩallah al Kubrá	2
Atlanta	2
Boardman	2
Bogotá	2
Bologna	2
Brescia	2
Campinas	2
Chiang Mai	2
Chiba	2
Columbia	2
Dongguan	2
Frankfurt am Main	2
Guangzhou	2
Haikou	2
Lana	2
Leicestershire	2
Madrid	2
Miaoli	2
Montreal	2
Mumbai	2
Nanjing	2
New Delhi	2
Phoenix	2
Pieve di Soligo	2
Totale	1.039

Nome	#
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients	272
Targeting immune dysregulation mediated by FLIP and putative FLIP-related pathways to develop new therapeutic approaches	229
Unraveling the role of lymph node metastasis in PDAC and dCCA progression	200
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis	165
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC	156
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer	152
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome	124
Local ablation disrupts immune evasion in pancreatic cancer	114
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.	104
Moonlighting Proteins Are Important Players in Cancer Immunology	83
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma	75
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response	74
Totale	1.748

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	2	0	0	0	0	0	0	0	0	0	0	0	2
2021/2022	58	1	7	10	3	2	0	12	7	9	0	2	5
2022/2023	111	4	14	19	22	3	21	2	11	9	2	2	2
2023/2024	183	2	4	7	23	11	19	14	13	0	29	46	15
2024/2025	654	36	27	25	70	31	41	90	90	104	22	37	81
2025/2026	740	71	60	86	178	308	37	0	0	0	0	0	0
Totale													1.748

CATALOGO DEI PRODOTTI DELLA RICERCA